NCT00262613View on ClinicalTrials.gov

Sodium Pyruvate Therapy in COPD Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

May 31, 2006

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

sodium pyruvate in 0.9% sodium chloride solution

Trial Locations (2)

06053

Hospital for Special Care, New Britain

06520-8057

Yale University School of Medicine, New Haven

Sponsors

Collaborators (1)

Cellular Sciences, inc.

All Listed Sponsors

collaborator

Cellular Sciences, inc.

INDUSTRY

lead

Emphycorp

INDUSTRY

NCT00262613 - Sodium Pyruvate Therapy in COPD Patients | Biotech Hunter | Biotech Hunter